Tejnaksh Healthcare Ltd
TEJNAKSHTejnaksh Healthcare Ltd
TEJNAKSHPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
21.80 | 2.00 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Tejnaksh Healthcare Limited is engaged in hospital activities. The Company offers healthcare services at 13 urology clinics, four urology hospitals and two dental super specialty clinics. The Company is operating one hospital at Dhule in Maharashtra.
Peers
Compare with peersMax Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 4.78 | 7.47 | 14.53 | 21.31 | 17.46 | 12.10 | 12.83 | 12.04 | 12.49 | 12.85 | ||||||||||
Raw Materials | 0.71 | 0.96 | 1.61 | 1.31 | 1.10 | 0.96 | 1.44 | 1.34 | 1.40 | 8.35 | ||||||||||
Power & Fuel Cost | 0.14 | 0.23 | 0.20 | 0.36 | 0.33 | 0.25 | 0.22 | 0.24 | 0.26 | |||||||||||
Employee Cost | 0.20 | 0.76 | 2.05 | 2.93 | 2.55 | 1.39 | 1.32 | 1.37 | 1.37 | |||||||||||
Selling & Administrative Expenses | 1.09 | 2.04 | 3.06 | 7.28 | 5.66 | 3.67 | 3.17 | 3.48 | 3.95 | |||||||||||
Operating & Other expenses | 0.31 | 0.10 | 1.88 | 3.70 | 3.44 | 1.98 | 1.77 | 1.59 | 1.56 | |||||||||||
EBITDA | 2.33 | 3.38 | 5.73 | 5.73 | 4.38 | 3.85 | 4.91 | 4.02 | 3.95 | 4.50 | ||||||||||
Depreciation/Amortization | 0.21 | 0.35 | 0.47 | 0.59 | 0.65 | 0.68 | 0.67 | 0.87 | 0.91 | 1.00 | ||||||||||
PBIT | 2.12 | 3.03 | 5.26 | 5.14 | 3.73 | 3.17 | 4.24 | 3.15 | 3.04 | 3.50 | ||||||||||
Interest & Other Items | 0.00 | 0.20 | 0.98 | 0.78 | 0.76 | 0.50 | 0.48 | 0.62 | 0.66 | 0.56 | ||||||||||
PBT | 2.12 | 2.83 | 4.28 | 4.36 | 2.97 | 2.67 | 3.76 | 2.53 | 2.38 | 2.94 | ||||||||||
Taxes & Other Items | 0.80 | 1.02 | 1.41 | 1.34 | 0.88 | 0.62 | 1.04 | 0.83 | 0.60 | 0.72 | ||||||||||
Net Income | 1.32 | 1.81 | 2.87 | 3.02 | 2.09 | 2.05 | 2.72 | 1.70 | 1.78 | 2.22 | ||||||||||
EPS | 0.65 | 0.89 | 1.41 | 1.49 | 1.03 | 1.01 | 1.34 | 0.84 | 0.88 | 1.09 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Tejnaksh Healthcare Ltd | 27.18 | 2.00 | — |
Max Healthcare Institute Ltd | 102.68 | 12.92 | 0.13% |
Apollo Hospitals Enterprise Ltd | 116.14 | 14.26 | 0.22% |
Fortis Healthcare Ltd | 89.98 | 6.30 | 0.14% |
Price Comparison
Compare TEJNAKSH with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
TEJNAKSH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Net profit of Tejnaksh Healthcare rose 6.90% to Rs 0.62 crore in the quarter ended September 2024 as against Rs 0.58 crore during the previous quarter ended September 2023. Sales rose 9.06% to Rs 3.37 crore in the quarter ended September 2024 as against Rs 3.09 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.373.09 9 OPM %34.1236.89 - PBDT1.141.05 9 PBT0.830.83 0 NP0.620.58 7 Powered by Capital Market - Live
Tejnaksh Healthcare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Tejnaksh Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Tejnaksh Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net profit of Tejnaksh Healthcare rose 275.00% to Rs 0.60 crore in the quarter ended June 2024 as against Rs 0.16 crore during the previous quarter ended June 2023. Sales rose 2.97% to Rs 3.12 crore in the quarter ended June 2024 as against Rs 3.03 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.123.03 3 OPM %34.6217.16 - PBDT1.030.44 134 PBT0.800.21 281 NP0.600.16 275 Powered by Capital Market - Live
Tejnaksh Healthcare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -10.13%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.06% to 0.02%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -10.03%, vs industry avg of 42.9%